3.23.1 html 365 375 1 true 103 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://pyxisoncology.com/20230331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://pyxisoncology.com/20230331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://pyxisoncology.com/20230331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://pyxisoncology.com/20230331/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://pyxisoncology.com/20230331/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Sheet http://pyxisoncology.com/20230331/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited-parentheticals Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://pyxisoncology.com/20230331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Statement - Consolidated Balance Sheets Sheet http://pyxisoncology.com/20230331/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 8 false false R9.htm 008 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://pyxisoncology.com/20230331/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 9 false false R10.htm 009 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://pyxisoncology.com/20230331/role/statement-consolidated-statements-of-operations-and-comprehensive-loss Consolidated Statements of Operations and Comprehensive Loss Statements 10 false false R11.htm 010 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://pyxisoncology.com/20230331/role/statement-consolidated-statements-of-stockholders-equity Consolidated Statements of Stockholders' Equity Statements 11 false false R12.htm 011 - Statement - Consolidated Statements of Stockholders' Equity (Parentheticals) Sheet http://pyxisoncology.com/20230331/role/statement-consolidated-statements-of-stockholders-equity-parentheticals Consolidated Statements of Stockholders' Equity (Parentheticals) Statements 12 false false R13.htm 012 - Statement - Consolidated Statements of Cash Flows Sheet http://pyxisoncology.com/20230331/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 13 false false R14.htm 013 - Disclosure - Note 1 - Organization and Description of the Business Sheet http://pyxisoncology.com/20230331/role/statement-note-1-organization-and-description-of-the-business Note 1 - Organization and Description of the Business Notes 14 false false R15.htm 014 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 15 false false R16.htm 015 - Disclosure - Note 3 - Merger (10Q) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q Note 3 - Merger (10Q) Notes 16 false false R17.htm 016 - Disclosure - Note 4 - Fair Value Measurement (10Q) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q Note 4 - Fair Value Measurement (10Q) Notes 17 false false R18.htm 017 - Disclosure - Note 5 - Balance Sheet Components (10 Q) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q- Note 5 - Balance Sheet Components (10 Q) Notes 18 false false R19.htm 018 - Disclosure - Note 6 - Stockholder's Equity Sheet http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity Note 6 - Stockholder's Equity Notes 19 false false R20.htm 019 - Disclosure - Note 7 - Public and Private Warrants Sheet http://pyxisoncology.com/20230331/role/statement-note-7-public-and-private-warrants Note 7 - Public and Private Warrants Notes 20 false false R21.htm 020 - Disclosure - Note 8 - Equity Plans and Related Equity Activities Sheet http://pyxisoncology.com/20230331/role/statement-note-8-equity-plans-and-related-equity-activities Note 8 - Equity Plans and Related Equity Activities Notes 21 false false R22.htm 021 - Disclosure - Note 9 - Commitments and Contingencies Sheet http://pyxisoncology.com/20230331/role/statement-note-9-commitments-and-contingencies Note 9 - Commitments and Contingencies Notes 22 false false R23.htm 022 - Disclosure - Note 10 - Income Taxes Sheet http://pyxisoncology.com/20230331/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 23 false false R24.htm 023 - Disclosure - Note 11 - Net Loss Per Share Sheet http://pyxisoncology.com/20230331/role/statement-note-11-net-loss-per-share Note 11 - Net Loss Per Share Notes 24 false false R25.htm 024 - Disclosure - Note 12 - Subsequent Event Sheet http://pyxisoncology.com/20230331/role/statement-note-12-subsequent-event Note 12 - Subsequent Event Notes 25 false false R26.htm 025 - Disclosure - Note 1 - Organization and Description of the Business Sheet http://pyxisoncology.com/20230331/role/statement-note-1-organization-and-description-of-the-businessA333C5D9-19D0-4567-932F-9815DE5E9A16 Note 1 - Organization and Description of the Business Notes 26 false false R27.htm 026 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies2BD6C28F-50E7-4037-A60B-045979707453 Note 2 - Summary of Significant Accounting Policies Notes 27 false false R28.htm 027 - Disclosure - Note 3 - Merger Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger Note 3 - Merger Notes 28 false false R29.htm 028 - Disclosure - Note 4 - Fair Value Measurement Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement Note 4 - Fair Value Measurement Notes 29 false false R30.htm 029 - Disclosure - Note 5 - Balance Sheet Components Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components Note 5 - Balance Sheet Components Notes 30 false false R31.htm 030 - Disclosure - Note 6 - Lease Sheet http://pyxisoncology.com/20230331/role/statement-note-6-lease Note 6 - Lease Notes 31 false false R32.htm 031 - Disclosure - Note 7 - Stockholder's Equity Sheet http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity Note 7 - Stockholder's Equity Notes 32 false false R33.htm 032 - Disclosure - Note 8 - Public and Private Warrants Sheet http://pyxisoncology.com/20230331/role/statement-note-8-public-and-private-warrants Note 8 - Public and Private Warrants Notes 33 false false R34.htm 033 - Disclosure - Note 9 - Equity Plans and Related Equity Activities Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities Note 9 - Equity Plans and Related Equity Activities Notes 34 false false R35.htm 034 - Disclosure - Note 10 - Commitments and Contingencies Sheet http://pyxisoncology.com/20230331/role/statement-note-10-commitments-and-contingencies Note 10 - Commitments and Contingencies Notes 35 false false R36.htm 035 - Disclosure - Note 11 - Income Taxes Sheet http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes Note 11 - Income Taxes Notes 36 false false R37.htm 036 - Disclosure - Note 12 - Net Loss Per Share Sheet http://pyxisoncology.com/20230331/role/statement-note-12-net-loss-per-share Note 12 - Net Loss Per Share Notes 37 false false R38.htm 037 - Disclosure - Note 13 - 401(k) Plan Sheet http://pyxisoncology.com/20230331/role/statement-note-13-401k-plan Note 13 - 401(k) Plan Notes 38 false false R39.htm 038 - Disclosure - Note 14 - Subsequent Events Sheet http://pyxisoncology.com/20230331/role/statement-note-14-subsequent-events Note 14 - Subsequent Events Notes 39 false false R40.htm 039 - Disclosure - Significant Accounting Policies (Policies) Sheet http://pyxisoncology.com/20230331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies 40 false false R41.htm 040 - Disclosure - Note 3 - Merger (10Q) (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q-tables Note 3 - Merger (10Q) (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q 41 false false R42.htm 041 - Disclosure - Note 4 - Fair Value Measurement (10Q) (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q-tables Note 4 - Fair Value Measurement (10Q) (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q 42 false false R43.htm 042 - Disclosure - Note 5 - Balance Sheet Components (10 Q) (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q-tables Note 5 - Balance Sheet Components (10 Q) (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q- 43 false false R44.htm 043 - Disclosure - Note 6 - Stockholder's Equity (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity-tables Note 6 - Stockholder's Equity (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity 44 false false R45.htm 044 - Disclosure - Note 7 - Public and Private Warrants (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-public-and-private-warrants-tables Note 7 - Public and Private Warrants (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-7-public-and-private-warrants 45 false false R46.htm 045 - Disclosure - Note 8 - Equity Plans and Related Equity Activities (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-8-equity-plans-and-related-equity-activities-tables Note 8 - Equity Plans and Related Equity Activities (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-8-equity-plans-and-related-equity-activities 46 false false R47.htm 046 - Disclosure - Note 11 - Net Loss Per Share (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-net-loss-per-share-tables Note 11 - Net Loss Per Share (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-11-net-loss-per-share 47 false false R48.htm 047 - Disclosure - Note 3 - Merger (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-tables Note 3 - Merger (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q 48 false false R49.htm 048 - Disclosure - Note 4 - Fair Value Measurement (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-tables Note 4 - Fair Value Measurement (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q 49 false false R50.htm 049 - Disclosure - Note 5 - Balance Sheet Components (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-tables Note 5 - Balance Sheet Components (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q- 50 false false R51.htm 050 - Disclosure - Note 6 - Lease (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-lease-tables Note 6 - Lease (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-6-lease 51 false false R52.htm 051 - Disclosure - Note 7 - Stockholder's Equity (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity-tables Note 7 - Stockholder's Equity (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity 52 false false R53.htm 052 - Disclosure - Note 9 - Equity Plans and Related Equity Activities (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-tables Note 9 - Equity Plans and Related Equity Activities (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities 53 false false R54.htm 053 - Disclosure - Note 11 - Income Taxes (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes-tables Note 11 - Income Taxes (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes 54 false false R55.htm 054 - Disclosure - Note 12 - Net Loss Per Share (Tables) Sheet http://pyxisoncology.com/20230331/role/statement-note-12-net-loss-per-share-tables Note 12 - Net Loss Per Share (Tables) Tables http://pyxisoncology.com/20230331/role/statement-note-12-net-loss-per-share 55 false false R56.htm 055 - Disclosure - Note 1 - Organization and Description of the Business (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-1-organization-and-description-of-the-business-details-textual Note 1 - Organization and Description of the Business (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-1-organization-and-description-of-the-business 56 false false R57.htm 056 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies2BD6C28F-50E7-4037-A60B-045979707453 57 false false R58.htm 057 - Disclosure - Note 3 - Merger (10Q) (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q-details-textual Note 3 - Merger (10Q) (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q-tables 58 false false R59.htm 058 - Disclosure - Note 3 - Merger - Schedule of Elements of Business Combination (10Q) (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-schedule-of-elements-of-business-combination-10q-details Note 3 - Merger - Schedule of Elements of Business Combination (10Q) (Details) Details 59 false false R60.htm 059 - Disclosure - Note 4 - Fair Value Measurement (10Q) (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q-details-textual Note 4 - Fair Value Measurement (10Q) (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q-tables 60 false false R61.htm 060 - Disclosure - Note 4 - Fair Value Measurement - Financial Instruments on Recurring Basis (10Q) (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-financial-instruments-on-recurring-basis-10q-details Note 4 - Fair Value Measurement - Financial Instruments on Recurring Basis (10Q) (Details) Details 61 false false R62.htm 061 - Disclosure - Note 4 - Fair Value Measurement - Estimated Fair Value of Marketable Securities and Gross Unrealized Holding Gains and Losses (10Q) (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-estimated-fair-value-of-marketable-securities-and-gross-unrealized-holding-gains-and-losses-10q-details Note 4 - Fair Value Measurement - Estimated Fair Value of Marketable Securities and Gross Unrealized Holding Gains and Losses (10Q) (Details) Details 62 false false R63.htm 062 - Disclosure - Note 5 - Balance Sheet Components (10 Q) (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q-details-textual Note 5 - Balance Sheet Components (10 Q) (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q-tables 63 false false R64.htm 063 - Disclosure - Note 5 - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (10Q) (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-summary-of-prepaid-expenses-and-other-current-assets-10q-details Note 5 - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (10Q) (Details) Details 64 false false R65.htm 064 - Disclosure - Note 5 - Balance Sheet Components - Summary of Property, Plant and Equipment (10Q) (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-summary-of-property-plant-and-equipment-10q-details Note 5 - Balance Sheet Components - Summary of Property, Plant and Equipment (10Q) (Details) Details 65 false false R66.htm 065 - Disclosure - Note 5 - Balance Sheet Components - Summary of Accrued Liabilities (10Q) (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-summary-of-accrued-liabilities-10q-details Note 5 - Balance Sheet Components - Summary of Accrued Liabilities (10Q) (Details) Details 66 false false R67.htm 066 - Disclosure - Note 6 - Stockholder's Equity (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity-details-textual Note 6 - Stockholder's Equity (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity-tables 67 false false R68.htm 067 - Disclosure - Note 6 - Stockholder's Equity - Summary of Convertible Preferred Stock (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity-summary-of-convertible-preferred-stock-details Note 6 - Stockholder's Equity - Summary of Convertible Preferred Stock (Details) Details 68 false false R69.htm 068 - Disclosure - Note 6 - Stockholder's Equity - Summary of Common Stock Reserved for Issuance (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-stockholders-equity-summary-of-common-stock-reserved-for-issuance-details Note 6 - Stockholder's Equity - Summary of Common Stock Reserved for Issuance (Details) Details 69 false false R70.htm 069 - Disclosure - Note 7 - Public and Private Warrants (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-public-and-private-warrants-details-textual Note 7 - Public and Private Warrants (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-7-public-and-private-warrants-tables 70 false false R71.htm 070 - Disclosure - Note 7 - Public and Private Warrants - Measurement Inputs and Valuation Techniques of Warrants (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-public-and-private-warrants-measurement-inputs-and-valuation-techniques-of-warrants-details Note 7 - Public and Private Warrants - Measurement Inputs and Valuation Techniques of Warrants (Details) Details 71 false false R72.htm 071 - Disclosure - Note 8 - Equity Plans and Related Equity Activities (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-8-equity-plans-and-related-equity-activities-details-textual Note 8 - Equity Plans and Related Equity Activities (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-8-equity-plans-and-related-equity-activities-tables 72 false false R73.htm 072 - Disclosure - Note 8 - Equity Plans and Related Equity Activities - Stock-based Compensation Expense (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-8-equity-plans-and-related-equity-activities-stockbased-compensation-expense-details Note 8 - Equity Plans and Related Equity Activities - Stock-based Compensation Expense (Details) Details 73 false false R74.htm 073 - Disclosure - Note 9 - Commitments and Contingencies (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-commitments-and-contingencies-details-textual Note 9 - Commitments and Contingencies (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-9-commitments-and-contingencies 74 false false R75.htm 074 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-10-income-taxes 75 false false R76.htm 075 - Disclosure - Note 11 - Net Loss Per Share - Antidilutive Securities (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-net-loss-per-share-antidilutive-securities-details Note 11 - Net Loss Per Share - Antidilutive Securities (Details) Details 76 false false R77.htm 076 - Disclosure - Note 1 - Organization and Description of the Business (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-1-organization-and-description-of-the-business-details-textualB5161F24-A199-4D9A-9D11-680B80832079 Note 1 - Organization and Description of the Business (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-1-organization-and-description-of-the-business 77 false false R78.htm 077 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual7D6D06FA-0969-409C-A7DF-3DF6C1F20DA9 Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-2-summary-of-significant-accounting-policies2BD6C28F-50E7-4037-A60B-045979707453 78 false false R79.htm 078 - Disclosure - Note 3 - Merger (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-details-textual Note 3 - Merger (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-3-merger-10q-tables 79 false false R80.htm 079 - Disclosure - Note 3 - Merger - Schedule of Elements of Business Combination (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-3-merger-schedule-of-elements-of-business-combination-details Note 3 - Merger - Schedule of Elements of Business Combination (Details) Details 80 false false R81.htm 080 - Disclosure - Note 4 - Fair Value Measurement (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-details-textual Note 4 - Fair Value Measurement (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-10q-tables 81 false false R82.htm 081 - Disclosure - Note 4 - Fair Value Measurement - Financial Instruments on Recurring Basis (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-financial-instruments-on-recurring-basis-details Note 4 - Fair Value Measurement - Financial Instruments on Recurring Basis (Details) Details 82 false false R83.htm 082 - Disclosure - Note 4 - Fair Value Measurement - Estimated Fair Value of Marketable Securities and Gross Unrealized Holding Gains and Losses (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-4-fair-value-measurement-estimated-fair-value-of-marketable-securities-and-gross-unrealized-holding-gains-and-losses-details Note 4 - Fair Value Measurement - Estimated Fair Value of Marketable Securities and Gross Unrealized Holding Gains and Losses (Details) Details 83 false false R84.htm 083 - Disclosure - Note 5 - Balance Sheet Components (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-details-textual Note 5 - Balance Sheet Components (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-10-q-tables 84 false false R85.htm 084 - Disclosure - Note 5 - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-summary-of-prepaid-expenses-and-other-current-assets-details Note 5 - Balance Sheet Components - Summary of Prepaid Expenses and Other Current Assets (Details) Details 85 false false R86.htm 085 - Disclosure - Note 5 - Balance Sheet Components - Summary of Property, Plant and Equipment (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-summary-of-property-plant-and-equipment-details Note 5 - Balance Sheet Components - Summary of Property, Plant and Equipment (Details) Details 86 false false R87.htm 086 - Disclosure - Note 5 - Balance Sheet Components - Summary of Accrued Liabilities (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-5-balance-sheet-components-summary-of-accrued-liabilities-details Note 5 - Balance Sheet Components - Summary of Accrued Liabilities (Details) Details 87 false false R88.htm 087 - Disclosure - Note 6 - Lease (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-lease-details-textual Note 6 - Lease (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-6-lease-tables 88 false false R89.htm 088 - Disclosure - Note 6 - Lease - Maturity of Operating Lease (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-6-lease-maturity-of-operating-lease-details Note 6 - Lease - Maturity of Operating Lease (Details) Details 89 false false R90.htm 089 - Disclosure - Note 7 - Stockholder's Equity (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity-details-textual Note 7 - Stockholder's Equity (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity-tables 90 false false R91.htm 090 - Disclosure - Note 7 - Stockholder's Equity - Summary of Convertible Preferred Stock (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity-summary-of-convertible-preferred-stock-details Note 7 - Stockholder's Equity - Summary of Convertible Preferred Stock (Details) Details 91 false false R92.htm 091 - Disclosure - Note 7 - Stockholder's Equity - Summary of Common Stock Reserved for Issuance (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-7-stockholders-equity-summary-of-common-stock-reserved-for-issuance-details Note 7 - Stockholder's Equity - Summary of Common Stock Reserved for Issuance (Details) Details 92 false false R93.htm 092 - Disclosure - Note 8 - Public and Private Warrants (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-8-public-and-private-warrants-details-textual Note 8 - Public and Private Warrants (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-8-public-and-private-warrants 93 false false R94.htm 093 - Disclosure - Note 9 - Equity Plans and Related Equity Activities (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-details-textual Note 9 - Equity Plans and Related Equity Activities (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-tables 94 false false R95.htm 094 - Disclosure - Note 9 - Equity Plans and Related Equity Activities - Stock-based Compensation Expense (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-stockbased-compensation-expense-details Note 9 - Equity Plans and Related Equity Activities - Stock-based Compensation Expense (Details) Details 95 false false R96.htm 095 - Disclosure - Note 9 - Equity Plans and Related Equity Activities - Schedule of Valuation Assumptions of Stock Options (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-schedule-of-valuation-assumptions-of-stock-options-details Note 9 - Equity Plans and Related Equity Activities - Schedule of Valuation Assumptions of Stock Options (Details) Details 96 false false R97.htm 096 - Disclosure - Note 9 - Equity Plans and Related Equity Activities - Summary of Activities Under the Plans (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-summary-of-activities-under-the-plans-details Note 9 - Equity Plans and Related Equity Activities - Summary of Activities Under the Plans (Details) Details 97 false false R98.htm 097 - Disclosure - Note 9 - Equity Plans and Related Equity Activities - Exercise Price Range of Options (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-9-equity-plans-and-related-equity-activities-exercise-price-range-of-options-details Note 9 - Equity Plans and Related Equity Activities - Exercise Price Range of Options (Details) Details 98 false false R99.htm 098 - Disclosure - Note 10 - Commitments and Contingencies (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-10-commitments-and-contingencies-details-textual Note 10 - Commitments and Contingencies (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-10-commitments-and-contingencies 99 false false R100.htm 099 - Disclosure - Note 11 - Income Taxes (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes-details-textual Note 11 - Income Taxes (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes-tables 100 false false R101.htm 100 - Disclosure - Note 11 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes-reconciliation-of-effective-income-tax-rate-details Note 11 - Income Taxes - Reconciliation of Effective Income Tax Rate (Details) Details 101 false false R102.htm 101 - Disclosure - Note 11 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details Note 11 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Details 102 false false R103.htm 102 - Disclosure - Note 11 - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-11-income-taxes-schedule-of-unrecognized-tax-benefits-details Note 11 - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) Details 103 false false R104.htm 103 - Disclosure - Note 12 - Net Loss Per Share - Antidilutive Securities (Details) Sheet http://pyxisoncology.com/20230331/role/statement-note-12-net-loss-per-share-antidilutive-securities-details Note 12 - Net Loss Per Share - Antidilutive Securities (Details) Details 104 false false R105.htm 104 - Disclosure - Note 13 - 401(k) Plan (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-13-401k-plan-details-textual Note 13 - 401(k) Plan (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-13-401k-plan 105 false false R106.htm 105 - Disclosure - Note 14 - Subsequent Events (Details Textual) Sheet http://pyxisoncology.com/20230331/role/statement-note-14-subsequent-events-details-textual Note 14 - Subsequent Events (Details Textual) Details http://pyxisoncology.com/20230331/role/statement-note-14-subsequent-events 106 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 55 fact(s) appearing in ix:hidden were eligible for transformation: pyxs:ConcentrationRiskCreditRiskOffBalanceSheetAmount, pyxs:MaximumAmountOfPurchaseOfCommonStock, pyxs:NumberOfDaysCommencesForSharePurchaseAfterTheClosingAndTerminatingOnTheFiveyearAnniversary, pyxs:NumberOfTradingDaysForDeterminingSharePrice, us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts, us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EquityMethodInvestmentOwnershipPercentage, us-gaap:IncomeTaxExpenseBenefit, us-gaap:OperatingLeaseExpense, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction, us-gaap:SaleOfStockPricePerShare, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod, us-gaap:StockIssuedDuringPeriodValueOther, us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 - pyxs20230603_s4.htm 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70 pyxs20230603_s4.htm ex_530086.htm ex_530087.htm ex_530233.htm ex_530667.htm ex_530755.htm pyxs-20230331.xsd pyxs-20230331_cal.xml pyxs-20230331_def.xml pyxs-20230331_lab.xml pyxs-20230331_pre.xml apexigen01.jpg apexigenbusiness02.jpg ccp01.jpg image01.jpg image02.jpg image03.jpg image04.jpg image07.jpg image08.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true